| Name | 1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-ol |
|---|
| Molecular Formula | C10H17N3O2 |
|---|---|
| Molecular Weight | 211.26100 |
| Exact Mass | 211.13200 |
| PSA | 62.39000 |
| LogP | 1.21910 |
|
~73%
832714-37-1 |
| Literature: ARENA PHARMACEUTICALS, INC. Patent: WO2005/7658 A2, 2005 ; Location in patent: Page 199-200 ; WO 2005/007658 A2 |
|
~33%
832714-37-1 |
| Literature: BRISTOL-MYERS SQUIBB COMPANY; YE, Xiang-Yang; WACKER, Dean A.; ROBL, Jeffrey A.; WANG, Ying Patent: WO2011/140160 A1, 2011 ; Location in patent: Page/Page column 129 ; WO 2011/140160 A1 |
|
~%
832714-37-1 |
| Literature: ARENA PHARMACEUTICALS, INC. Patent: WO2005/121121 A2, 2005 ; Location in patent: Page/Page column 166 ; WO 2005/121121 A2 |
|
~%
832714-37-1 |
| Literature: BRISTOL-MYERS SQUIBB COMPANY; YE, Xiang-Yang; WACKER, Dean A.; ROBL, Jeffrey A.; WANG, Ying Patent: WO2011/140160 A1, 2011 ; WO 2011/140160 A1 |